E

Evotec SE
XETRA:EVT

Watchlist Manager
Evotec SE
XETRA:EVT
Watchlist
Price: 8.41 EUR 0.06% Market Closed
Market Cap: 1.5B EUR
Have any thoughts about
Evotec SE?
Write Note

Evotec SE
Investor Relations

Nestled within Germany's innovation-focused sector, Evotec SE has carved a niche for itself as a leading player in the field of drug discovery and development solutions. From its inception, Evotec has thrived on its commitment to delivering comprehensive solutions that expedite the journey from conceptualization to clinical success. At the core of its business model is a robust and scalable platform approach, which integrates cutting-edge technologies such as high-throughput screening, phenotypic screening, and computational biology. By leveraging these advanced methodologies, Evotec collaborates with pharmaceutical giants, biotech firms, and academic institutions, offering them customized services and shared-risk alliances. This symbiotic partnership model not only accelerates drug discovery but also minimizes the resource constraints typically associated with early-stage research.

Evotec's revenue generation is intricately tied to its partnerships and collaborations, which involve milestone and royalty payments, alongside direct service fees. Its business strategy is propelled by a unique combination of proprietary drug development initiatives and strategic collaborative ventures. This dual-pronged approach allows Evotec to share the financial risk of drug development while maintaining potential upside through successful compounds. Moreover, the company's proactive investments in its own pipeline complement the service-based revenue, as they position Evotec to capture significant gains from future licensing or the eventual commercialization of internally researched drugs. With a strong emphasis on scientific excellence and commercial viability, Evotec meticulously balances innovation with strategic foresight, crafting a sustainable business that stands resilient amid the ever-evolving pharmaceutical landscape.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Ms. Laetitia Rouxel
CFO & Member of Management Board
No Bio Available
Dr. Christian Wojczewski
Chief Executive Officer
No Bio Available
Ms. Aurelie Dalbiez
Chief People Officer & Member of Management Board
No Bio Available
Mr. Volker Braun
Executive VP and Head of Global Investor Relations & ESG
No Bio Available
Dr. Christian Dargel
EVP Global Head of Legal & Compliance
No Bio Available
Gabriele Hansen
Senior VP & Head of Global Corporate Communications & Marketing
No Bio Available
Dr. Ian M. Hunneyball
Senior Vice President of Programme Management & Clinical Operations
No Bio Available
Dr. David Hallet
Executive Vice President
No Bio Available
Uwe Andag
EVP Head of Metabolic Diseases
No Bio Available
Ms. Christiane Honisch
SVP Head of Diagnostics
No Bio Available

Contacts

Address
HAMBURG
Hamburg
Essener Bogen 7
Contacts
+4940560810.0
www.evotec.com